HeartBeam, Inc. – NASDAQ:BEAT

Founder-led company

HeartBeam stock price today

$1.09
-1.16
-51.77%
Financial Health
0
1
2
3
4
5
6
7
8
9

HeartBeam stock price monthly change

-27.10%
month

HeartBeam stock price quarterly change

-27.10%
quarter

HeartBeam stock price yearly change

-0.44%
year

HeartBeam key metrics

Market Cap
65.32M
Enterprise value
N/A
P/E
-1.33
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
6.29
PEG ratio
-0.01
EPS
-0.61
Revenue
N/A
EBITDA
-15.94M
Income
-15.10M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

HeartBeam stock price history

HeartBeam stock forecast

HeartBeam financial statements

HeartBeam, Inc. (NASDAQ:BEAT): Profit margin
Jun 2023 0 -3.15M
Sep 2023 0 -3.47M
Dec 2023 0 -3.87M
Mar 2024 0 -4.60M
HeartBeam, Inc. (NASDAQ:BEAT): Analyst Estimates
Sep 2025 600K -3.68M -614.34%
Oct 2025 2.82M -2.38M -84.46%
Dec 2025 3.12M -3.43M -110.03%
Dec 2025 3.72M -2.38M -64.05%
  • Analysts Price target

  • Financials & Ratios estimates

HeartBeam, Inc. (NASDAQ:BEAT): Earnings per share (EPS)
2022-11-10 -0.32 -0.44
2023-03-16 -0.55228 -0.45
HeartBeam, Inc. (NASDAQ:BEAT): Debt to assets
Jun 2023 21632000 570K 2.63%
Sep 2023 19648000 1.01M 5.19%
Dec 2023 17131000 1.19M 6.97%
Mar 2024 13635000 1.09M 8.05%
HeartBeam, Inc. (NASDAQ:BEAT): Cash Flow
Jun 2023 -4.02M -3.93K 24.37M
Sep 2023 -2.09M 3.79M 111K
Dec 2023 -2.85M -112K -24.99M
Mar 2024 -3.46M -88K 0

HeartBeam alternative data

HeartBeam, Inc. (NASDAQ:BEAT): Employee count
Aug 2023 10
Sep 2023 10
Oct 2023 10
Nov 2023 10
Dec 2023 13
Jan 2024 13
Feb 2024 13
Apr 2024 15
May 2024 15
Jun 2024 15
Jul 2024 13

HeartBeam other data

2.11% -1.42%
of BEAT is owned by hedge funds
172.00K -114.89K
shares is hold by hedge funds

HeartBeam, Inc. (NASDAQ:BEAT): Insider trades (number of shares)
Period Buy Sel
Sep 2023 0 42979
Transaction Date Insider Security Shares Price per share Total value Source
Sale
DE URIOSTE GEORGE director
Common Stock 5,500 $2.06 $11,330
Sale
DE URIOSTE GEORGE director
Common Stock 8,000 $2.04 $16,320
Sale
DE URIOSTE GEORGE director
Common Stock 1,834 $2.11 $3,870
Sale
DE URIOSTE GEORGE director
Common Stock 5,000 $2.09 $10,450
Sale
DE URIOSTE GEORGE director
Common Stock 2,393 $2.21 $5,289
Sale
DE URIOSTE GEORGE director
Common Stock 100 $2.41 $241
Sale
DE URIOSTE GEORGE director
Common Stock 883 $2.46 $2,172
Sale
DE URIOSTE GEORGE director
Common Stock 5,000 $2.46 $12,300
Sale
DE URIOSTE GEORGE director
Common Stock 4,269 $2.43 $10,374
Sale
DE URIOSTE GEORGE director
Common Stock 5,000 $2.17 $10,850
Monday, 23 December 2024
businesswire.com
Monday, 16 December 2024
businesswire.com
Tuesday, 19 November 2024
businesswire.com
Saturday, 9 November 2024
seekingalpha.com
Thursday, 7 November 2024
businesswire.com
Thursday, 31 October 2024
businesswire.com
Thursday, 24 October 2024
businesswire.com
Thursday, 17 October 2024
businesswire.com
Wednesday, 14 August 2024
seekingalpha.com
Tuesday, 25 June 2024
businesswire.com
Friday, 14 June 2024
prnewswire.com
Monday, 20 May 2024
businesswire.com
Monday, 13 May 2024
businesswire.com
Sunday, 12 May 2024
Seeking Alpha
Thursday, 25 April 2024
Business Wire
Tuesday, 9 April 2024
Business Wire
Wednesday, 20 March 2024
InvestorPlace
Seeking Alpha
Tuesday, 5 March 2024
Business Wire
Tuesday, 31 October 2023
Business Wire
Sunday, 13 August 2023
Seeking Alpha
Sunday, 14 May 2023
Seeking Alpha
Thursday, 13 April 2023
Seeking Alpha
Friday, 17 March 2023
Seeking Alpha
Friday, 16 December 2022
Seeking Alpha
Saturday, 12 November 2022
Seeking Alpha
Tuesday, 25 October 2022
Business Wire
Monday, 24 October 2022
24/7 Wall Street
Monday, 17 October 2022
24/7 Wall Street
Thursday, 13 October 2022
Business Wire
  • What's the price of HeartBeam stock today?

    One share of HeartBeam stock can currently be purchased for approximately $1.09.

  • When is HeartBeam's next earnings date?

    Unfortunately, HeartBeam's (BEAT) next earnings date is currently unknown.

  • Does HeartBeam pay dividends?

    No, HeartBeam does not pay dividends.

  • How much money does HeartBeam make?

    HeartBeam has a market capitalization of 65.32M. HeartBeam made a loss 14.64M US dollars in net income (profit) last year or -$0.45 on an earnings per share basis.

  • What is HeartBeam's stock symbol?

    HeartBeam, Inc. is traded on the NASDAQ under the ticker symbol "BEAT".

  • What is HeartBeam's primary industry?

    Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.

  • How do i buy shares of HeartBeam?

    Shares of HeartBeam can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are HeartBeam's key executives?

    HeartBeam's management team includes the following people:

    • Dr. Branislav Vajdic Ph.D. Founder, Chief Executive Officer & Director(age: 70, pay: $81,860)
    • Mr. Richard D. Brounstein Chief Financial Officer(age: 75, pay: $35,950)
  • Is HeartBeam founder-led company?

    Yes, HeartBeam is a company led by its founder Dr. Branislav Vajdic Ph.D..

  • How many employees does HeartBeam have?

    As Jul 2024, HeartBeam employs 13 workers, which is 13% less then previous month and 13% less then previous quarter.

  • When HeartBeam went public?

    HeartBeam, Inc. is publicly traded company for more then 3 years since IPO on 11 Nov 2021.

  • What is HeartBeam's official website?

    The official website for HeartBeam is heartbeam.com.

  • Where are HeartBeam's headquarters?

    HeartBeam is headquartered at 2118 Walsh Avenue, Santa Clara, CA.

  • How can i contact HeartBeam?

    HeartBeam's mailing address is 2118 Walsh Avenue, Santa Clara, CA and company can be reached via phone at +40 88994443.

HeartBeam company profile:

HeartBeam, Inc.

heartbeam.com
Exchange:

NASDAQ

Full time employees:

15

Industry:

Medical - Healthcare Information Services

Sector:

Healthcare

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

2118 Walsh Avenue
Santa Clara, CA 95050

CIK: 0001779372
ISIN: US42238H1086
CUSIP: 42238H108